ADVERTISEMENT
Breaking News
Breaking market news, earnings coverage, and in-depth interviews with industry leaders.
Latest News
467 articles
Breaking News
Pangaea Logistics Solutions Ltd (PANL) Reports Q4 Earnings
Pangaea Logistics Solutions Ltd (PANL) turned in Q4 2025 gaap EPS of $0.18, undershooting the $0.23 Street estimate...
Breaking News
SolarEdge (SEDG) Q4 Loss Narrows to $0.14/Share vs $0.24 Estimate, Stock Jumps 10%
SolarEdge narrows Q4 loss to $0.14/share vs $0.24 estimate, stock jumps 10% despite cautious Q1 guidance of $290M-$320M...
Breaking News
Groupon Inc. (GRPN) Misses Q4 EPS Estimates
Groupon Inc (GRPN) posted Q4 2025 gaap EPS of $0.17, falling short of the $0.50 estimate (miss by...
Breaking News
CRISPR Therapeutics (CRSP) Reports Wider Q4 Loss of $1.37/Share on Zero Revenue; Shares Plunge 10%
CRISPR Therapeutics posts wider-than-expected Q4 loss of $1.37/share on zero revenue; shares sink 10% as cash burn accelerates.
Breaking News
Cadre Holdings, Inc. (CDRE) Misses Q4 EPS Estimates
**Cadre Holdings Reports Q4 2025 Earnings Miss**
Breaking News
Broadwind Energy (BWEN) Posts Q4 Loss of $0.05/Share, Revenue Climbs 10% to $37M
Broadwind Energy reports Q4 loss of $0.05 per share on revenue of $37M, up 10% year-over-year, with fiscal...
Breaking News
Serve Robotics Inc (SERV) Reports Wider Q4 Loss Than Expected
Serve Robotics Inc (SERV) posted a Q4 2025 adjusted loss of $0.49 per share, wider than the -$0.44...
Breaking News
Acacia Research (ACTG) Q4 Adjusted EPS Surges 122.5% YoY to $0.03, Revenue Reaches $50.1M
Acacia Research reports Q4 adjusted EPS of $0.03, up 122.5% year-over-year, with revenue of $50.1M rising 2.6% from...
Breaking News
Acacia Research Corp (ACTG) Reports Q4 Earnings
Acacia Research Corp (ACTG) reported fourth-quarter 2025 financial results. Acacia Research Corp (ACTG) posted Q4 2025 adjusted EPS...
Breaking News
Minerva Neurosciences, Inc (NERV) Reports Q4 Earnings
**Minerva Neurosciences Reports Q4 2025 Results**
Breaking News
Verrica Pharmaceuticals inc (VRCA) Reports Q4 Earnings
**Verrica Pharmaceuticals Reports Q4 2025 Results**